Market Cap
Merck & Co., Inc.
$281.30 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$287.63 B |
![]() |
$285.80 B |
![]() |
$259.51 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Merck & Company, Inc., known as Merck Sharp & Dohme, or MSD, outside the United States and Canada, is one of the largest pharmaceutical companies in the world. Founded in 1891 in the US, and independent since World War I from its parent company, now one of the largest companies in Germany, Merck provides prescription medicines, vaccines, biologic therapies, and animal health products.
Merck & Co., Inc. has the following listings and related stock indices.
Stock: NYSE: MRK
Stock: Euronext: MRK
Stock: FSX: 6MK
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.